A citation-based method for searching scientific literature

Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
Times Cited: 199







List of co-cited articles
467 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
604
73

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
140
46

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
109
40

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
38

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
109
27


The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
139
21

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
404
19

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.
Ava S Runge, Lynn Kennedy, Adam S Brown, Abigail E Dove, Brian J Levine, Sophie P Koontz, Varun S Iyengar, Sarah A Odeh, Kelly L Close, Irl B Hirsch,[...]. Clin Diabetes 2018
40
42

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
144
17

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Yun Shen, Qiang Wu, Ren Wang, Lei Zhang, Yifei Mo, Wei Lu, Wei Zhu, Yuqian Bao,[...]. Diabetes Technol Ther 2020
47
36

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
128
15


State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
511
14

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
263
14


Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol Ther 2018
75
16

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
359
12


Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Laura Mayeda, Ronit Katz, Iram Ahmad, Nisha Bansal, Zona Batacchi, Irl B Hirsch, Nicole Robinson, Dace L Trence, Leila Zelnick, Ian H de Boer. BMJ Open Diabetes Res Care 2020
21
52

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Jingyi Lu, Chunfang Wang, Yun Shen, Lei Chen, Lei Zhang, Jinghao Cai, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. Diabetes Care 2021
16
68


Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes.
Irl B Hirsch, Jennifer L Sherr, Korey K Hood. Diabetes Care 2019
22
45


Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Suresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne S L Gardner. Diabetes Technol Ther 2018
43
23

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, Davida F Kruger, Anne L Peters, Irl Hirsch, Richard M Bergenstal, Elena Toschi, Andrew J Ahmann, Viral N Shah,[...]. Diabetes Care 2017
123
10

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
Martin Tauschmann, Hood Thabit, Lia Bally, Janet M Allen, Sara Hartnell, Malgorzata E Wilinska, Yue Ruan, Judy Sibayan, Craig Kollman, Peiyao Cheng,[...]. Lancet 2018
118
10

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
185
10



Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.
Lorena Alarcon-Casas Wright, Irl B Hirsch. Diabetes Technol Ther 2017
71
12

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
158
9

ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes.
Linda A DiMeglio, Carlo L Acerini, Ethel Codner, Maria E Craig, Sabine E Hofer, Kubendran Pillay, David M Maahs. Pediatr Diabetes 2018
168
9

Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Jee Hee Yoo, Min Sun Choi, Jiyeon Ahn, Sung Woon Park, Yejin Kim, Kyu Yeon Hur, Sang-Man Jin, Gyuri Kim, Jae Hyeon Kim. Diabetes Technol Ther 2020
17
52



Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
823
8

Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.
Qingyu Guo, Pu Zang, Shaoying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu,[...]. J Diabetes Res 2020
19
42

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
254
7

Continuous glucose monitoring and intensive treatment of type 1 diabetes.
William V Tamborlane, Roy W Beck, Bruce W Bode, Bruce Buckingham, H Peter Chase, Robert Clemons, Rosanna Fiallo-Scharer, Larry A Fox, Lisa K Gilliam, Irl B Hirsch,[...]. N Engl J Med 2008
929
7

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
Denice S Feig, Lois E Donovan, Rosa Corcoy, Kellie E Murphy, Stephanie A Amiel, Katharine F Hunt, Elizabeth Asztalos, Jon F R Barrett, J Johanna Sanchez, Alberto de Leiva,[...]. Lancet 2017
194
7

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.
Karl Kristensen, Linda E Ögge, Verena Sengpiel, Karin Kjölhede, Annika Dotevall, Anders Elfvin, Filip K Knop, Nana Wiberg, Anastasia Katsarou, Nael Shaat,[...]. Diabetologia 2019
32
21

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. Diabetes Technol Ther 2013
148
7



Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes.
Ajenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, Peter Rossing, Steen Andersen, Kirsten Nørgaard. Diabetes Care 2020
10
70

The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.
Robert A Vigersky, John Shin, Boyi Jiang, Thorsten Siegmund, Chantal McMahon, Andreas Thomas. J Diabetes Sci Technol 2018
23
26


Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
6

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
Dongyuan Xing, Craig Kollman, Roy W Beck, William V Tamborlane, Lori Laffel, Bruce A Buckingham, Darrell M Wilson, Stuart Weinzimer, Rosanna Fiallo-Scharer, Katrina J Ruedy. Diabetes Technol Ther 2011
55
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.